Wolf Mueller
Affiliations: | Neuropathology | Ruprecht-Karls-University Heidelberg, Heidelberg, Baden-Württemberg, Germany |
Website:
http://www.medicalnewstoday.com/articles/162605.phpGoogle:
"Wolf Mueller"Mean distance: 16.49 (cluster 24) | S | N | B | C | P |
Cross-listing: Neuropathology Tree
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Muench A, Teichmann D, Spille D, et al. (2023) A Novel Type of IDH Wild-type Glioma Characterized by Gliomatosis Cerebri-like Growth Pattern, TERT Promoter Mutation, and Distinct Epigenetic Profile. The American Journal of Surgical Pathology |
Sievers P, Henneken SC, Blume C, et al. (2021) Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors. Acta Neuropathologica |
Wallenborn M, Xu LX, Kirsten H, et al. (2020) Molecular analyses of glioblastoma stem-like cells and glioblastoma tissue. Plos One. 15: e0234986 |
Reinhardt A, Stichel D, Schrimpf D, et al. (2018) Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathologica |
Capper D, Jones DTW, Sill M, et al. (2018) DNA methylation-based classification of central nervous system tumours. Nature |
Drachsler M, Kleber S, Mateos A, et al. (2016) CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells. Cell Death & Disease. 7: e2209 |
Kratz A, Sahm F, Schrimpf D, et al. (2016) HG-68COMBINED ALTERATIONS IN MAPK PATHWAY GENES, CDKN2A/B AND ATRX CHARACTERIZE ANAPLASTIC PILOCYTIC ASTROCYTOMA Neuro-Oncology. 18: iii63.2-iii63 |
Xu LX, Holland H, Kirsten H, et al. (2015) Three gangliogliomas: results of GTG-banding, SKY, genome-wide high resolution SNP-array, gene expression and review of the literature. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 35: 148-57 |
Sahm F, Reuss D, Koelsche C, et al. (2014) Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma. Acta Neuropathologica. 128: 551-9 |
Sahm F, Reuss D, Koelsche C, et al. (2014) Ge-30Oligoastrocytoma Does Not Exist: In-Situ Molecular Genetics Favors Classification As Either Oligodendroglioma Or Astrocytoma Neuro-Oncology. 16 |